These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [The biology of lymphatic vessels - new findings ]. Jussila L; Alitalo K; Kaipainen A Duodecim; 1998; 114(4):343-8. PubMed ID: 11466946 [No Abstract] [Full Text] [Related]
5. Signalling via vascular endothelial growth factor receptor-3 is sufficient for lymphangiogenesis in transgenic mice. Veikkola T; Jussila L; Makinen T; Karpanen T; Jeltsch M; Petrova TV; Kubo H; Thurston G; McDonald DM; Achen MG; Stacker SA; Alitalo K EMBO J; 2001 Mar; 20(6):1223-31. PubMed ID: 11250889 [TBL] [Abstract][Full Text] [Related]
6. Still more debate over VEGF. Isner JM Nat Med; 2001 Jun; 7(6):639-41. PubMed ID: 11385475 [No Abstract] [Full Text] [Related]
7. Development of the avian lymphatic system. Wilting J; Papoutsi M; Othman-Hassan K; Rodriguez-Niedenführ M; Pröls F; Tomarev SI; Eichmann A Microsc Res Tech; 2001 Oct; 55(2):81-91. PubMed ID: 11596153 [TBL] [Abstract][Full Text] [Related]
8. A strategy for antitumor vascular therapy by targeting the vascular endothelial growth factor: receptor complex. Cooke SP; Boxer GM; Lawrence L; Pedley RB; Spencer DI; Begent RH; Chester KA Cancer Res; 2001 May; 61(9):3653-9. PubMed ID: 11325835 [TBL] [Abstract][Full Text] [Related]
9. Lymphatic versus blood vascular endothelial growth factors and receptors in humans. Partanen TA; Paavonen K Microsc Res Tech; 2001 Oct; 55(2):108-21. PubMed ID: 11596156 [TBL] [Abstract][Full Text] [Related]
10. Lymphangiogenesis and tumor metastasis: more questions than answers. Pepper MS Lymphology; 2000 Dec; 33(4):144-7. PubMed ID: 11191654 [No Abstract] [Full Text] [Related]
11. VEGF-D is the strongest angiogenic and lymphangiogenic effector among VEGFs delivered into skeletal muscle via adenoviruses. Rissanen TT; Markkanen JE; Gruchala M; Heikura T; Puranen A; Kettunen MI; Kholová I; Kauppinen RA; Achen MG; Stacker SA; Alitalo K; Ylä-Herttuala S Circ Res; 2003 May; 92(10):1098-106. PubMed ID: 12714562 [TBL] [Abstract][Full Text] [Related]
12. Vascular endothelial growth factor (VEGF) receptor-2 antagonists inhibit VEGF- and basic fibroblast growth factor-induced angiogenesis in vivo and in vitro. Tille JC; Wood J; Mandriota SJ; Schnell C; Ferrari S; Mestan J; Zhu Z; Witte L; Pepper MS J Pharmacol Exp Ther; 2001 Dec; 299(3):1073-85. PubMed ID: 11714897 [TBL] [Abstract][Full Text] [Related]
13. An avian model for studies of embryonic lymphangiogenesis. Wilting J; Schneider M; Papoutski M; Alitalo K; Christ B Lymphology; 2000 Sep; 33(3):81-94. PubMed ID: 11019398 [TBL] [Abstract][Full Text] [Related]